In the news

This next-generation transcatheter aortic valve implantation (TAVI) technology is a new platform designed with a number of features to improve upon the clinical performance of the original ACURATE neo platform.

Boston Scientific and IBM Research are working together to make chronic pain treatment more individualized—and effective.

“The motive is educating the community,” said Camille Chang Gilmore, global chief diversity officer at Boston Scientific. “We’ve been doing this for 16 years, and we’ve now evolved it to try and figure out how do we bring these resources to people.”

Vercise Genus, a fourth-generation system for deep brain stimulation (DBS), made by Boston Scientific, has received CE marketing and is now commercially available in Europe.

Tune in at the 33-minute mark to hear Boston Scientific’s Brian Dunkin, MD, CMO, Endoscopy, and Dave Pierce, EVP of MedSurg, discuss the EXALT™ Model D single-use duodenoscope in the DeviceTalks Weekly podcast.

Meghan Scanlon hasn’t changed her leadership philosophy much over the years: “It’s to serve and build a high-performing team that can operate smoothly without me, but doesn’t want to.

“Employee resource groups like LEAD provide a huge opportunity for leaders to listen to workers from marginalized groups. Yet, at many companies, they exist in silos…. That's not the case at Boston Scientific.”

Wendy Carruthers, SVP of HR, shares how Boston Scientific is supporting working parents in Boston Globe Media.

In a recent Boston Globe Media column, Donna James—a member of the Boston Scientific board of directors since 2015—draws on her experiences as a Black female board member to call for bold action in pursuit of diverse representation.

"It's because we made all of those changes in the last few years that we were so well-positioned to make the swift, dramatic changes that COVID forced upon us," Chief Information Officer Jodi Eddy told Business Insider.